Cord blood procalcitonin and soluble urokinase-type plasminogen activator receptor in predicting histological chorioamnionitis - A pilot study. [PDF]
Jalkanen K +7 more
europepmc +1 more source
Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as a Biomarker of Neurodysfunction. [PDF]
de Rezende VL +4 more
europepmc +1 more source
Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock. [PDF]
Hongisto M +17 more
europepmc +1 more source
Modeling the role of urokinase-type plasminogen activator, uPA, and circulating cancer-associated fibroblasts (cCAFs) in breast cancer cell extravasation. [PDF]
Spartz A +5 more
europepmc +1 more source
Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects. [PDF]
El-Patal MA +7 more
europepmc +1 more source
Polypeptide inhibitors of urokinase type plasminogen activator
A conjugate which is capable of specific binding to and inhibition of urokinase-type plasminigen activator (UPA) comprising a polypeptide molecule and a scaffold molecule, wherein said polypeptide molecule is attached to said scaffold molecule by at ...
Winter, Greg +2 more
core
High serum urokinase-type plasminogen activator receptor correlates with sepsis-induced cardiomyopathy in sepsis patients. [PDF]
He J +7 more
europepmc +1 more source
Prognostic value of soluble urokinase-type plasminogen activator receptor in coronary artery disease: A meta-analysis. [PDF]
Li Y +5 more
europepmc +1 more source
The relationship between the urokinase-type plasminogen activator gene Pro141Leu polymorphism and patients with prostate cancer. [PDF]
Gülüm C +3 more
europepmc +1 more source
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Biomarker Associated with Left Ventricular Hypertrophy in the Elderly, Specifically in Women. [PDF]
Wlazeł RN +5 more
europepmc +1 more source

